Posted by Michael Wonder on 15 Jun 2021
Medtronic announces FDA approval of its next generation recharge-free spinal cord stimulation platform
10 June 2021 - Vanta implantable neurostimulator offers up to 11 year battery life and personalised pain relief.
Medtronic today announced it has received U.S. FDA approval for Vanta, a high performance recharge-free implantable neurostimulator with a device life that can be optimised up to 11 years.
